| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.033 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.04 | 0.9 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |